Search
for
Sort by
Research 571–600 of 1000+
- Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Combination Therapy With CGF and Microneedling‐Assisted Compound Betamethasone for Resistant Alopecia Areata: APilot Study
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- Myeloproliferative disorder associated with alopecia universalis
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Cisd2 deficiency impairs neutrophil function by regulating calcium homeostasis via Calnexin and SERCA
- CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Upadacitinib for the treatment of alopecia areata – A case report
- Alopecia Areata with Renal Dysgenesis
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Progression of Pseudolymphoma to true Cutaneous lymphoma, possible role of Platelet-rich plasma (PRP), a case report.
- A Cellular Study of Inflammatory Responses in Women with Polycystic Ovary Syndrome as: “An In vitro Model of Anti Breast Tumor Response”A Case Control Study
- SnapshotDx Quiz: February 2018
- SnapshotDx Quiz: August 2016
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review
- Hair Diseases (Alopecia Areata and Androgenetic Alopecia)
- Telogen effluvium as the first symptom of Crohn's disease in a child.
- Granzyme B in Autoimmune Skin Disease
- Study of the Thyroid Profile of Patients with Alopecia